Expression of PTEN and Caspase-3 and their clinicopathological significance in primary gastric malignant lymphoma

Chinese Medical Sciences Journal

Volumn 19, Issue 1, 2004, Pages 19-24

  Sun, Hongwei ^b   Zheng, Huachuan ^a   Yang, Xuefei ^a   Wu, Dongying ^a   Zhang, Sumin ^a   Kuang, Lige ^a   Xin, Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Caspase 3; Primary gastric malignant lymphoma; PTEN gene

Indexed keywords

BIOTIN; CASPASE 3; MOLECULAR MARKER; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; STREPTAVIDIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL MOTILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL PARAMETERS; NEOVASCULARIZATION (PATHOLOGY); PROTEIN DETERMINATION; PROTEIN EXPRESSION; STOMACH LYMPHOMA; STOMACH MUCOSA;

ADULT; AGED; CASPASE 3; CASPASES; DOWN-REGULATION; FEMALE; GASTRIC MUCOSA; HUMANS; LYMPHATIC METASTASIS; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 1842659897     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Steck PA, Pershouse MA, Jasser SA, et al. Identification of candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356-63.
2. Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet 2002;70:829-44.
3. Yang L, Kuang LG, Zheng HC, et al. PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma. World J Gastroenterol 2003;9:35-9.
4. Fernade-Alnemri T, Litwack G, Alnemri ES, et al. CPP32, a novel human apoptotic protein with homology to caenrohabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 1994;269:30761-4.
5. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
6. Wang X, Zelenski NG, Yang J, et al. Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J 1996;15:1012-20.
7. Tewari M, Quan LT, O'Rourke K, et al. Yama/CPP32, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 1995;81:801-9.
8. Kodera Y, Nakamura S, Yamamura Y, et al. Primary gastric B cell lymphoma: audit of 82 cases treated with surgery and classified according to the concept of mucosa-associated lymphoid tissue lymphoma. World J Surg 2000; 24:857-62.
9. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-7.
10. Garcia JM, Silva JM, Dominguez G, et al. Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res Treat 1999;57:237-43.
11. Lin WM, Forgacs E, Warshal DP, et al. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin Cancer Res 1998;4:2577-83.
12. Kang YH, Lee HS, Kim WH.Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest 2002; 82:285-91.
13. Lee JI, Soria JC, Hassan KA, et al. Loss of PTEN expression as a prognostic marker for tongue cancer. Arch Otolaryngol Head Neck Surg 2001;127:1441-5.
14. Verma RS, Manikal M, Conte RA, et al. Chromosomal basis of adenocarcinoma of the prostate. Cancer Inves 1999; 17:441-7.
15. McMenamin ME, Soung P, Perera S, et al. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res 1999;59:4291-6.
16. Hwang PH, Yi HK, Kim DS, et al. Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/ MMAC1/TEP1 gene. Cancer Lett 2001;172(1):83-91
17. Maehama T, Taylor GS, Dixon JE. PTEN and myotubularin: novel phosphoinositide phosphatases. Annu Rev Biochem 2001;70:247-79.
18. Krajewska M, Wang HG, Krajewska S, et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res 1997;57:1605-13.
19. Sun BH, Zhang J, Wang BJ, et al. Analysis of in vivo patterns of caspase 3 gene expression in primary hepatocellular carcinoma and its relationship to p21 (WAF1) expression and hepatic apoptosis. World J Gastroenterol 2000;6:356-60.
20. O'Neill AJ, Boran SA, O'Keane C, et al. Caspase 3 expression in benign prostatic hyperplasia and prostate carcinoma. Prostate 2001;47:183-8.
21. Hoshi T, Sasano H, Kato K, et al. Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res 1998; 18:4347-53.
22. Schwartzbauer G, Robbins J. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J Biol Chem 2001;276:35786-93.
23. Carson JP, Kulik G, Weber MJ. Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3′-kinase and Akt/protein kinase B. Cancer Res 1999;59:1449-53.
24. Wick W, Furnari FB, Naumann U, et al. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis. Oncogene 1999;18:3936-43.